Squarepoint Ops LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

  • $59.6 Billion
  • Q2 2024

A detailed history of Squarepoint Ops LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 383,826 shares of ARWR stock, worth $7.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
383,826
Holding current value
$7.24 Million
% of portfolio
0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$21.87 - $28.24 $8.39 Million - $10.8 Million
383,826 New
383,826 $9.98 Million
Q2 2023

Aug 14, 2023
SELL
$25.16 - $41.38 $3.6 Million - $5.92 Million
-142,952 Reduced 74.19%
49,734 $1.77 Million
Q1 2023

May 15, 2023
BUY
$23.68 - $38.51 $4.42 Million - $7.18 Million
186,477 Added 3003.33%
192,686 $4.89 Million
Q4 2022

Feb 14, 2023
SELL
$28.0 - $40.56 $28,392 - $41,127
-1,014 Reduced 14.04%
6,209 $251,000
Q3 2022

Nov 14, 2022
SELL
$29.63 - $48.31 $3.82 Million - $6.24 Million
-129,072 Reduced 94.7%
7,223 $239,000
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $3.24 Million - $5.9 Million
116,502 Added 588.6%
136,295 $4.8 Million
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $784,198 - $1.38 Million
19,793 New
19,793 $910,000
Q4 2021

Feb 14, 2022
SELL
$58.09 - $82.51 $404,364 - $574,352
-6,961 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$58.38 - $84.96 $42,734 - $62,190
732 Added 11.75%
6,961 $435,000
Q2 2021

Aug 16, 2021
BUY
$62.15 - $90.32 $387,132 - $562,603
6,229 New
6,229 $516,000
Q4 2020

Feb 16, 2021
SELL
$43.82 - $85.37 $926,091 - $1.8 Million
-21,134 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$33.21 - $51.27 $130,780 - $201,901
-3,938 Reduced 15.71%
21,134 $910,000
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $1.12 Million - $1.86 Million
-42,948 Reduced 63.14%
25,072 $1.08 Million
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $1.26 Million - $3.86 Million
61,209 Added 898.68%
68,020 $1.96 Million
Q4 2019

Feb 14, 2020
SELL
$28.14 - $73.01 $184,992 - $479,967
-6,574 Reduced 49.11%
6,811 $432,000
Q3 2019

Nov 14, 2019
SELL
$26.26 - $34.86 $239,622 - $318,097
-9,125 Reduced 40.54%
13,385 $377,000
Q2 2019

Aug 14, 2019
SELL
$17.43 - $28.82 $1.19 Million - $1.96 Million
-68,144 Reduced 75.17%
22,510 $597,000
Q1 2019

May 15, 2019
BUY
$12.05 - $20.18 $900,195 - $1.51 Million
74,705 Added 468.4%
90,654 $1.66 Million
Q4 2018

Feb 14, 2019
BUY
$10.74 - $19.7 $171,292 - $314,195
15,949 New
15,949 $198,000
Q1 2018

May 15, 2018
SELL
$3.72 - $7.64 $190,464 - $391,168
-51,200 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$3.14 - $4.5 $109,272 - $156,600
34,800 Added 212.2%
51,200 $188,000
Q3 2017

Nov 14, 2017
BUY
$1.69 - $4.33 $27,716 - $71,012
16,400
16,400 $71,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
92.3M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email